Diabetes

SMRs in problematic polypharmacy: diabetes focus

10 February 2026Consultant pharmacists will use a case study to illustrate a patient centred approach to SMRs for patients with diabetes.

Considerations and interactions with GLP-1 receptor agonists

12 November 2025Signposting key risks and interactions of GLP-1 receptor agonists in diabetes, obesity, and weight management.

Primary care discussions: biosimilar insulin

30 September 2025Discussion about the considerations of implementing biosimilar insulin in primary care. Hints and tips for systems considering a move to biosimilar insulin.

Prescribing GLP-1 receptor agonists

26 March 2025Glucagon-like peptide-1 (GLP-1) receptor agonist availability is resolved. Supply content is maintained by DHSC.

'Flozin' suggestions for adults with swallowing difficulties

27 February 2025A range of SGLT2 inhibitor ('flozin') formulations are suitable for use in adults with swallowing difficulties

'Gliptin' suggestions for adults with swallowing difficulties

27 February 2025A range of DPP-4 inhibitor ('gliptin') formulations are suitable for use in adults with swallowing difficulties

Using antidiabetic medicines during breastfeeding

23 June 2023Insulin or metformin are the preferred choices during breastfeeding. Recommendations apply to full term and healthy infants only.